A MULTICENTER, RANDOMIZED TRIAL OF COMBINATION PEGYLATED INTERFERON-ALPHA 2A PLUS RIBAVIRIN VS. PEGYLATED INTERFERON-ALPHA 2A MONOTHERAPY IN LIVER TRANSPLANT RECIPIENTS WITH RECURRENT HEPATITIS C

被引:0
|
作者
Gane, Edward J. [1 ]
Strasser, Simone I. [2 ]
Crowford, Darrell H. [3 ]
Ring, John A. [4 ]
Rizkalla, Bishoy [5 ]
Thompson, Sandra J. [5 ]
McCaughan, Geoffrey W. [2 ]
机构
[1] Auckland City Hosp, New Zealand Liver Transplant Unit, Auckland, New Zealand
[2] Royal Prince Alfred Hosp, AW Morrow GI & Liver Ctr, Sydney, NSW, Australia
[3] Princess Alexandra Hosp, Dept Gastroenterol & Hepatol, Brisbane, Qld 4102, Australia
[4] Flinders Med Ctr, S Australia Liver Transplant Unit, Adelaide, SA, Australia
[5] Roche Prod Pty Ltd, Dee Why, NSW, Australia
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
191
引用
收藏
页码:393A / 394A
页数:2
相关论文
共 50 条
  • [31] Preliminary treatment results of pegylated interferon alpha 2b and ribavirin in liver transplant recipients with recurrent hepatitis C virus nonresponsive to interferon alpha2b and ribavirin
    Neff, GW
    Montalbano, M
    Ozden, N
    Muslu, H
    Lee, YM
    Safdar, K
    Morrero, R
    Nery, J
    Weppler, D
    Madariaga, J
    Levi, D
    Nashida, S
    Kato, T
    Schiff, E
    Tzakis, A
    JOURNAL OF HEPATOLOGY, 2003, 38 : 160 - 160
  • [32] Airway haemangioma treated with interferon-alpha 2a
    Suskan, Emine
    Tekin, Deniz
    Atay, Guelsuem
    Yagmurlu, Aydin
    Ugur, Handan
    Tacyildiz, Nurdan
    ACTA PAEDIATRICA, 2008, 97 (04) : 393 - 394
  • [33] Antiviral/Immunomodulatory Combination Therapy: Pegylated Interferon Alpha 2a and Ribavirin in Patients with Chronic Hepatitis C Virus Infection
    Delic, Dragan
    Mitrovic, Nikola
    Popovic, Natasa
    Urosevic, Aleksandar
    Pesic, Ivana
    Simonovic, Jasmina
    Dulovic, Olga
    Svirtlih, Neda
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2012, 140 (9-10) : 612 - 618
  • [34] Pegylated interferon α-2a and ribavirin combination therapy in HCV liver transplant recipients.: Experience of 7 cases
    Iacob, Speranta
    Gheorghe, Liana
    Hrehoret, Doina
    Becheanu, Gabriel
    Herlea, Vlad
    Popescu, Irinel
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2008, 17 (02) : 165 - 172
  • [35] Pegylated interferon-alpha plus taurine in treatment of rat liver fibrosis
    Ilker Tasci
    Mehmet Refik Mas
    Sevil Atalay Vural
    Salih Deveci
    Bilgin Comert
    Gunay Alcigir
    Nuket Mas
    Cemal Akay
    Mithat Bozdayi
    Cihan Yurdaydin
    Hakan Bozkaya
    Ozden Uzunalimoglu
    Ahmet Turan Isik
    Harun M Said
    World Journal of Gastroenterology, 2007, (23) : 3237 - 3244
  • [36] Clinical investigation of the immunogenicity of interferon-alpha 2a
    Ryff, JC
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1997, 17 : S29 - S33
  • [37] Pegylated interferon-alpha plus taurine in treatment of rat liver fibrosis
    Tasci, Ilker
    Mas, Mehmet Refik
    Vural, Sevil Atalay
    Deveci, Salih
    Comert, Bilgin
    Alcigir, Gunay
    Mas, Nuket
    Akay, Cemal
    Bozdayi, Mithat
    Yurdaydin, Cihan
    Bozkaya, Hakan
    Uzunalimoglu, Ozden
    Isik, Ahmet Turan
    Said, Harun M.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (23) : 3237 - 3244
  • [38] Serum procalcitonin levels in chronic hepatitis C patients under pegylated interferon-alpha plus ribavirin treatment
    Elefsiniotis, Ioannis S.
    Petrocheilou, Aikaterini
    Scarmeas, Nikolaos
    Ketikoglou, Ioannis
    Pantazis, Konstantinos D.
    Toutouza, Marina
    Tsianos, Epameinondas V.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 37 (04) : 329 - 331
  • [39] Treatment of hepatitis C in hemodialysis patients with pegylated interferon α-2a as monotherapy
    Sikole, Aleksandar
    Dzekova, Pavlina
    Selja, Nexhmi
    Gaseva, Magdalena
    Nikolov, Igor G.
    Zabzun, Mustafa
    Muharemi, Sheriat
    Asani, Arben
    Amitov, Vili
    Mena, Sami
    Grunevska, Violeta
    Ivanovski, Ljubomir
    Polenakovic, Momir
    RENAL FAILURE, 2007, 29 (08) : 961 - 966
  • [40] Preliminary treatment results of liver transplant recipients with recurrent hepatitis C virus nonresponsive to interferon alpha2B and ribavirin using combination pegylated interferon alpha 2B with ribavirin.
    Neff, GW
    Montalbano, M
    Lee, YM
    Slapak, G
    Safdar, K
    Morrero, R
    Nery, J
    Weppler, D
    Demodina, M
    Schiff, E
    Tzakis, A
    HEPATOLOGY, 2002, 36 (04) : 183A - 183A